ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,312Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 2094

$1.32M Total Retail Price of All Prescriptions

Rank: 36 out of 2094

409 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 409 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

4% of this provider’s 409 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 10,767 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$81 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
METOPROLOL SUCCINATE 584 468 1 9
ATORVASTATIN CALCIUM 514 357 2 5
OMEPRAZOLE 471 311 3 4
AMLODIPINE BESYLATE 442 331 4 2
SIMVASTATIN 344 270 5 1
ZOLPIDEM TARTRATE 341 180 6 14
ENALAPRIL MALEATE 326 179 7 25
DIOVAN 274 196 8 13
PROAIR HFA 271 140 9 45
HYDROCHLOROTHIAZIDE 239 192 10 12
FLUTICASONE PROPIONATE 230 138 11 41
TRAMADOL HCL 223 158 12 33
GABAPENTIN 223 100 12 23
METFORMIN HCL 222 128 14 8
LEVOTHYROXINE SODIUM 216 172 15 3
IBUPROFEN 209 122 16 73
FUROSEMIDE 202 144 17 6
ENDOCET 199 109 S2 18 88
CARVEDILOL 191 110 19 19
ADVAIR DISKUS 189 167 20 36
FAMOTIDINE 178 134 21 34
DONEPEZIL HCL 174 174 22 20
SINGULAIR 172 101 23 64
VOLTAREN 169 123 24 109
LOSARTAN POTASSIUM 162 129 25 17
METOPROLOL TARTRATE 153 124 26 10
ALENDRONATE SODIUM 153 123 26 30
JANUVIA 148 122 28 35
OXYCODONE-ACETAMINOPHEN 140 128 S2 29 40
CLOPIDOGREL 134 94 30 22
NEXIUM 130 102 31 16
DIOVAN HCT 126 122 32 28
LIPITOR 126 109 32 39
LEVEMIR FLEXPEN 124 77 34 188
LOVAZA 121 60 35 53
PLAVIX 119 89 36 38
OXYCODONE HCL 118 17 S2 37 63
SYMBICORT 116 26 38 149
QUINAPRIL HCL 115 85 39 123
CELEBREX 111 63 40 74
ENALAPRIL-HYDROCHLOROTHIAZIDE 105 69 41 213
NASONEX 104 54 42 194
SERTRALINE HCL 102 34 43 26
ESCITALOPRAM OXALATE 101 81 44 46
LANTUS SOLOSTAR 100 56 45 76
JANUMET 99 54 46 86
FEXOFENADINE HCL 96 71 47 191
HYDRALAZINE HCL 95 77 48 89
LISINOPRIL 95 51 48 7
MONTELUKAST SODIUM 94 44 50 128
GLYBURIDE-METFORMIN HCL 94 66 R 50 94
PEN NEEDLE 92 48 52 136
IBANDRONATE SODIUM 89 73 53 140
GLIMEPIRIDE 88 48 54 31
SPIRIVA 88 50 54 60
NOVOLOG FLEXPEN 87 62 56 142
LOSARTAN-HYDROCHLOROTHIAZIDE 84 58 57 52
GLYBURIDE 83 73 R 58 95
ACTOS 82 60 59 112
VENTOLIN HFA 82 48 59 132
NAMENDA 81 81 61 32
LACTULOSE 79 43 62 65
PHENYTOIN SODIUM EXTENDED 77 39 63 158
POTASSIUM CHLORIDE 77 72 63 24
OXYCONTIN 75 32 S2 65 98
NIFEDIPINE ER 70 65 66 96
CILOSTAZOL 67 39 67 204
HYDROCORTISONE 67 33 67 268
GLIPIZIDE 67 36 67 82
METFORMIN HCL ER 66 53 70 67
CYCLOBENZAPRINE HCL 65 17 R 71 115
TAMSULOSIN HCL 64 44 72 29
ZETIA 63 40 73 79
LANSOPRAZOLE 62 24 74 144
NOVOLOG MIX 70-30 FLEXPEN 62 47 74 307
LYRICA 61 53 76 85
BENICAR HCT 60 26 77 133
MORPHINE SULFATE ER 60 26 S2 77 192
SPIRONOLACTONE 60 26 77 93
EXFORGE 60 43 77 105
LIDODERM 60 16 77 59
COMBIVENT 59 57 82 211
CLONIDINE HCL 57 32 83 62
PREDNISONE 57 26 83 54
RANITIDINE HCL 56 27 85 80
AMITRIPTYLINE HCL 56 34 R 85 178
WARFARIN SODIUM 55 32 87 11
GEMFIBROZIL 53 39 88 223
PRAVASTATIN SODIUM 53 43 88 18
POLYETHYLENE GLYCOL 3350 51 43 90 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 8, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.